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ABSTRACT: Despite criticism that health reform legislation will result in cuts to Medicare, 
the bills passed by the House of Representatives and the Senate, as well as President 
Obama’s proposal, contain provisions that would strengthen the program by reducing costs 
for prescription drugs, expanding coverage for preventive care, providing more help for 
low-income beneficiaries, and supporting accessible, coordinated, and comprehensive care 
that effectively responds to patients’ needs. The legislation also would help to extend the 
program’s fiscal solvency—for nine years, under the Senate bill. This issue brief exam-
ines the provisions in the pending legislation and how each one would work to improve 
benefits, extend the fiscal solvency of the Medicare Hospital Insurance Trust Fund, reduce 
pressure on the federal budget, and contribute to moving the health care system toward 
better access to care, improved quality, and greater efficiency.
                    
OveRvieW
The pending health reform legislation (i.e., the bills passed by the House of 
Representatives and the Senate, as well as President Obama’s proposal, which 
builds on those bills) contains several provisions that would strengthen the 
Medicare program for beneficiaries. These provisions would help reduce costs for 
prescription drugs, expand coverage for preventive care, provide more help for 
low-income beneficiaries, and support accessible, coordinated, and comprehen-
sive care that effectively responds to patients’ needs.
Some critics have characterized these changes as cuts to the Medicare pro-
gram, arguing that they represent a reduction in benefits. In fact, all beneficiaries 
would continue to be guaranteed all of Medicare’s basic benefits, and those ben-
efits would be improved with the expansion of coverage for preventive care and 
reduction in costs for prescription drugs. 
The way hospitals and other health care providers are paid would be 
changed to focus more on the quality and effectiveness of care that patients 
receive. New initiatives aimed at improving the organization and delivery of care 
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promise to improve care coordination and effective-
ness and slow cost growth. The Medicare savings that 
would come from improved productivity would help 
sustain the fiscal solvency of the Medicare Hospital 
Insurance Trust Fund while reducing beneficiary pre-
miums and the program’s draw on tax revenues, rela-
tive to current projections. 
Health reform legislation therefore would 
improve benefits for most Medicare beneficiaries, 
extend the fiscal solvency of the program, and begin 
to move the health care system toward better access to 
care, improved quality, and greater efficiency.1
Medicare and the Health Care System
As the largest payer for health care—accounting for 20 
percent of U.S. national health expenditures in 2008 
for its almost 45 million beneficiaries—Medicare plays 
a central role in the health system.2 Like the rest of 
the system, it is plagued by rapidly rising costs. The 
Hospital Insurance (Part A) Trust Fund, which pays 
for hospital and other facility-based services used 
by Medicare beneficiaries and is financed by an ear-
marked payroll tax, is projected to become insolvent by 
2017 under current law.3 Both Supplementary Medical 
Insurance (Part B), which pays for physician and other 
ambulatory care and medical supplies, and Prescription 
Drug Coverage (Part D) are financed by beneficiaries’ 
monthly premiums and open-ended draws on general 
revenues, so they are fully-financed by definition, but 
they represent a progressively greater burden on both 
beneficiaries’ resources and the federal government’s 
budget. The total Part A Trust Fund deficit, plus the 
draw on general revenues to cover Part B and Part D 
costs in excess of beneficiary premiums under current 
law, has a present value (i.e., the amount in today’s 
dollars that would be necessary to cover those costs) of 
$88.9 trillion—or 6.8 percent of gross domestic prod-
uct (GDP)—if nothing is done.4 
The increasing number of retirees from the baby 
boom generation is often cited as a threat to Medicare’s 
future. However, it is primarily the systemwide growth 
in health care spending per person that drives the 
projected growth in Medicare spending (Exhibit 1). 
Medicare is therefore both an important part of the 
problem that health reform is intended to address and a 
victim of those problems. Medicare’s problems cannot 
be solved without addressing the causes of those prob-
lems, which reside throughout the health system. As 
such, Medicare can and should be both a key vehicle 
for developing approaches to slowing health spending 
growth and a major beneficiary of them.
Medicare Provisions in the Health  
Reform Legislation
The health reform legislation contains several provi-
sions that would affect Medicare and its beneficiaries 
(Exhibit 2).5 President Obama’s proposals are based 
largely on the Senate bill, with any differences indi-
cated explicitly below:
Prescription Drugs •	
Both the Senate and House bills would address 
the costs that beneficiaries face for prescription 
drugs and require more transparency to promote 
increased competition.
The Senate bill would require a 50 percent discount 
on brand-name drugs in the coverage gap (com-
monly known as the “doughnut hole”) for ben-
eficiaries with annual incomes below $85,000 or 
couples with incomes below $170,000. It reduces 
the coverage gap by $500 in 2010, but not any 
further in succeeding years. The Senate bill also 
would require pharmaceutical benefit managers to 
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Exhibit 1. Sources of Growth in Projected Federal Spending 
on Medicare and Medicaid, 2007 to 2082
Source: Congressional Budget Office, The Long-Term Outlook for Health Care 
Spending (Washington, D.C.: CBO, 2007), as presented by P. Orzag at the New 
America Foundation, Nov. 2007, accessible at:  
http://www.newamerica.net/files/Orzag%20PPT%20111307.pdf.
Percentage of GDP 
Effect of Excess Cost Growth
Effect of the Aging of the Population
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disclose discounts negotiated with drugmakers and 
pass on savings to consumers.
The House bill would require a 50 percent discount 
on brand-name drugs in the coverage gap for all 
beneficiaries, while counting the full price of those 
drugs in determining the threshold for catastrophic 
coverage, which would help reduce expenses for 
beneficiaries with high prescription drug costs. It 
also would phase out the coverage gap within 10 
years. The House bill would require the Secretary 
of Health and Human Services to negotiate directly 
with pharmaceutical manufacturers to lower drug 
prices for Medicare stand-alone prescription drug 
plans and Medicare Advantage plans, and it would 
require drug manufacturers to provide rebates 
for dual-eligibles (i.e., individuals eligible for 
both Medicare and Medicaid) who are enrolled in 
Medicare drug plans. The House bill also would 
require disclosure of financial relationships among 
health entities (e.g., between physicians and drug 
companies), and it would lift the current 36-month 
limit on coverage of drugs to prevent rejection of a 
kidney transplant. 
The president’s proposal, which is based largely 
on the Senate bill, would add a provision similar to 
that in the House bill that would close the coverage 
gap within 10 years. 
Preventive Services•	
Both the Senate and House bills would improve 
the coverage of preventive services by covering 
proven preventive services under Medicare and 
Medicaid and eliminating any cost-sharing for  
preventive services in Medicare. 
The Senate bill also would expand the number of 
covered preventive services, including an annual 
wellness visit under Medicare. 
Assistance for Low-Income Beneficiaries•	
The Senate and House bills contain provisions 
that would increase assistance for low-income 
beneficiaries.
The Senate bill would eliminate prescription drug 
copayments for certain dually eligible (Medicare 
and Medicaid) beneficiaries receiving home- or 
community-based long-term care. It also would 
Exhibit 2. Medicare Provisions in the Health Reform Legislation
Prescription drugs.•	  Reduce the cost of prescription drugs, narrow the coverage gap, and require  
more transparency.
Preventive services.•	  Expand coverage, eliminate cost-sharing.
Assistance	for	low-income	beneficiaries.•	  Eliminate prescription drug copayments for dual-eligibles.
Primary care.•	  Increase payments for primary care providers.
Care coordination.•	  Encourage development of more coordinated models of health care delivery.
Provider payments.•	  Adjust payments for expected productivity improvements, reward reduction of hospital-
acquired infections and avoidable hospital admissions.
Medicare Advantage.•	  Reduce overpayment of private Medicare Advantage plans.
Medicare solvency.•	  Extend solvency of Hospital Insurance Trust Fund.
Innovation.•	  Create Center for Medicare and Medicaid Innovation, providing platform for new approaches to 
payment and health care delivery.
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extend the spousal impoverishment protections 
available to spouses of persons in institutional 
care (i.e., provisions intended to protect some of 
the assets of spouses of people who “spend down” 
their assets to become eligible for Medicaid nurs-
ing home benefits) to spouses receiving home- and 
community-based care.
The House bill would eliminate prescription drug 
copayments for certain dually eligible (Medicare 
and Medicaid) beneficiaries receiving home- or 
community-based long-term care. It also would 
expand eligibility for the low-income subsidy 
that helps to pay drug premiums and copayments 
under Medicare’s Part D prescription drug benefit. 
In addition, it would expand eligibility for the 
Medicare Savings Programs that help low-income 
beneficiaries pay Medicare premiums, deductibles, 
and coinsurance under Parts A and B, by more 
than doubling the amount of allowable savings and 
other financial assets beneficiaries can have. It also 
extends the Qualified Individual program, which 
helps low-income beneficiaries pay for their Part B 
premium. It also pays some Medicare coinsurance 
and deductibles for disabled beneficiaries who 
have incomes below 150 percent of the federal 
poverty level and limited assets.
Primary Care•	
Both the Senate and House bills would enhance 
Medicare beneficiary access to primary care by 
increasing primary care provider payment rates. 
Patients with greater access to coordinated primary 
care report better care and better outcomes than 
patients who do not have such access.6
The Senate bill seeks to strengthen primary care by 
providing 10 percent bonus payments to primary 
care providers (and general surgeons) that would 
be in effect for five years. In addition, the Senate 
bill strengthens chronic care management by pro-
viding reimbursement for certain care management 
activities for patients with hospital stays related to 
a major chronic condition.7 
The House bill includes a permanent 5 percent 
payment bonus for evaluation and management 
services (i.e., office visits) and other services asso-
ciated with ensuring accessible, continuous, coor-
dinated, and comprehensive care when provided by 
a physician or other practitioner who specializes in 
family medicine, general internal medicine, general 
pediatrics, or geriatrics and for whom primary care 
represents a majority of his or her practice income. 
It provides an additional 5 percent allowance for 
practice in areas where there is a shortage of health 
professionals. Medicaid fees for primary care 
services, under both fee-for-service payment and 
managed care plans, would be raised to Medicare 
levels over a three-year period.
Care Coordination•	
Both the House and Senate bills establish initia-
tives that would encourage development of more 
coordinated models of health care delivery, including 
incentives for providers to form accountable care 
organizations that take joint responsibility for the 
quality and outcomes of their patients’ care while 
eliminating duplicative and wasteful care. They 
also establish initiatives that would provide extra 
payments and incentives for patient-centered medi-
cal homes, which improve access to primary care 
services and encourage coordination of patient care.
Provider Payments•	
Both the House and Senate bills would reduce the 
growth in payment rates for services provided by 
hospitals and other facilities, to extend the sol-
vency of the Medicare program. They also would 
reward reduction of hospital-acquired infection 
rates and avoidable hospital readmissions. A recent 
study found that 20 percent of Medicare beneficia-
ries who are discharged from the hospital are read-
mitted within 30 days—an occurrence that often 
represents poor care, hardship for the patient, and 
avoidable costs.8 
The Senate bill also establishes an Independent 
Payment Advisory Board with a mandate to reduce 
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provider payment rates to meet Medicare spending 
targets, preserve the program’s viability over time, 
and recommend other policy changes to reduce 
overall health spending growth. 
Medicare Advantage•	
Both the House and Senate bills would reduce 
the current overpayment of private Medicare 
Advantage plans, which drained an estimated $11 
billion from the Medicare program in 2009.9 With 
those extra payments, Medicare Advantage plans 
can offer some additional benefits to the minority 
(25 percent) of beneficiaries who are enrolled in 
private plans. However, these additional benefits 
are not available to the 75 percent of Medicare 
beneficiaries in traditional Medicare, despite the 
fact that they are paid for out of program funds 
contributed by all workers and taxpayers and 
exacerbate the looming threat to the program’s sol-
vency—as well as increasing the Part B premiums 
paid by all beneficiaries.
The Senate bill would set payments for Medicare 
Advantage plans based on bids submitted by each 
plan relative to the bids submitted by all plans in 
the area, providing bonus payments to plans that 
meet broadly defined quality or care coordination 
criteria. The Senate bill also would prohibit plans 
from charging enrollees more than traditional 
Medicare for certain medical services and would 
require plans to use bonus payments to reduce 
cost-sharing for medical services. It also would 
establish a single annual enrollment period during 
which private plan changes can be made.
The House bill would set payments for Medicare 
Advantage plans based on projected costs per 
beneficiary in traditional Medicare in each county, 
providing bonus payments to plans that provide 
high-quality care based on specific performance 
standards. The House bill also would prohibit 
plans from charging enrollees more than traditional 
Medicare for any medical services and limit plan 
profits and administrative expenses to 15 percent 
of Medicare payments and enrollee premiums. It 
also would establish a single annual enrollment 
period during which private plan changes can  
be made.
The president’s proposal would contain the provi-
sions in the Senate bill, except that payments for 
private plans would be set differently: they would 
be determined on a sliding scale depending on 
traditional Medicare costs in each area, with plans 
in low-cost areas receiving higher rates relative 
to the costs they face. High-performing plans (as 
measured by quality and patient experience crite-
ria) would receive extra payments relative to other 
plans in the same area.
Medicare Solvency•	
The net impact of the House bill would extend  
the solvency of the Part A Trust Fund by five years, 
to 2022.
The Senate bill would raise drug plan premiums 
for individuals with incomes over $85,000 or 
couples with incomes over $170,000, and would 
increase the Medicare Part A payroll tax by 0.9 
percentage points for individuals with incomes 
over $200,000 or couples with incomes over 
$250,000. The net impact of the Senate bill would 
extend the solvency of the Part A Trust Fund by 
nine years, to 2026.
Innovation•	
Perhaps the most important provision in the health 
reform legislation, which appears in similar forms 
in the two bills, is the creation of a Center for 
Medicare and Medicaid Innovation, which pro-
vides a platform for developing new approaches 
to paying for health care to encourage greater 
quality and efficiency. As described previously, 
the primary source of the financial pressure faced 
by the Medicare program is the excessive growth 
of health care costs throughout the health system. 
This growth is fueled by the current fee-for-service 
payment system, which rewards the provision of 
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more services, more complicated procedures, and 
more expensive care.10 The long-run viability of 
Medicare—and the health care system in general—
depends on moving toward a different way of pay-
ing for and providing care, one that is affordable 
for those who need it while providing value for the 
resources spent. 
Reductions in Cost Growth, Not Cuts
Some critics have characterized the improvements to 
the Medicare program as Medicare cuts, making ben-
eficiaries concerned that their benefits are being cut. In 
fact, all beneficiaries would continue to be guaranteed 
all of Medicare’s basic benefits. Those benefits would 
be improved—changes to the way hospitals and other 
health care providers are paid would enhance, not 
undermine, the quality of care. 
At the same time, Medicare savings that result 
from improved productivity and reduced overpayments 
would help sustain the fiscal solvency of the Medicare 
Hospital Insurance Trust Fund. The Congressional 
Budget Office estimates that changes to Medicare in 
the House and Senate bills would yield savings of $469 
billion and $387 billion, respectively, over the 10-year 
period, 2010–2019 (Exhibit 3). The largest contribu-
tions would come from changes to provider payments 
that would reflect increases in productivity, a decrease 
in the need to offset losses from treating the uninsured, 
and gradual elimination of overpayments to Medicare 
managed care plans that benefit insurance companies 
and a minority of beneficiaries at the expense of all 
Medicare beneficiaries. 
Even with the reduced spending growth under 
the House and Senate bills, the Medicare program 
would still grow over the next decade. Taken in the 
context of projected Medicare spending of more than 
$6 trillion over the next 10 years, the savings figures 
cited above are—while certainly meaningful—hardly 
earth-shaking. The 67 percent growth over the next 
decade under the House bill (5.3 percent per year)  
Exhibit 3. Estimated Reductions from Currently Projected Medicare Spending, 2010–2019, from 
Provisions in House and Senate Bills (dollars in billions)
CBO estimate of House Bill CBO estimate of Senate Bill 
Total Medicare Savings from Payment and 
System Reforms
–$469 –$387
Productivity improvement/provider payment 
updates
–177 –151
Medicare Advantage reform –170 –136
Primary care, geographic adjustment –9 2
Increased coverage of preventive services 3 4
Payment innovations –2 –8
Hospital readmissions –9 –7
Disproportionate share hospital adjustment –10 –24
Prescription drugs –50 6
Home health –55 –39
Independent board — –28
Savings and low-income subsidy program 12 —
Other improvements and interactions –2 –6
Source: Authors’ estimates based on Congressional Budget Office analysis of H.R. 3962, The Affordable Health Care for America Act, Nov. 20, 2009, http://www.cbo.gov/doc.
cfm?index=10741; and Congressional Budget Office analysis of the Patient Protection and Affordable Care Act, incorporating the Manager’s Amendment, Dec. 19, 2009,  
http://www.cbo.gov/doc.cfm?index=10868.
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and the 69 percent growth under the Senate bill (5.4 
percent per year) would be substantial reductions from 
the current projection of 89 percent (6.6 percent per 
year) (Exhibit 4). However, even those reduced growth 
rates are greater than projected growth in the rest of the 
U.S. economy: the U.S. GDP is projected to increase 
by 63 percent between 2009 and 2019 (5.0 percent  
per year).11 
Exhibit 4. Medicare Spending, 2010–2019:
Current Projection and Alternative Scenarios
Source: D. M. Cutler, K. Davis, and K. Stremikis, Why Health Reform Will Bend the 
Cost Curve (Washington, D.C., and New York: Center for American Progress and 
The Commonwealth Fund, Dec. 2009). 
6.6% annual 
growth  
Total 10-Year Medicare Payment and System 
Reform Savings Compared to Current Projection 
Senate – CBO $387 billion 
House – CBO $469 billion 
5.3% annual 
growth  
5.4% annual 
growth  
Billions
Current Projection
House - CBO
Senate - CBO
$797
$712
$705
$422
CONCLuSiONS
Health reform is essential to avoid the deteriorating 
access, mushrooming costs, and disappointing per-
formance that the U.S. health system faces. It is also 
critical to ensuring Medicare’s continued ability to pro-
vide elderly and disabled beneficiaries with access to 
needed care. Health reform legislation would improve 
benefits for Medicare beneficiaries, extend the fiscal 
solvency of the Medicare Hospital Insurance Trust 
Fund, reduce pressure on the federal budget, and con-
tribute to moving the health care system toward better 
access to care, improved quality, and greater efficiency. 
We need reform to put the U.S. health system on the 
path to high performance and move away from the 
fragmented, inefficient, and poor-quality system that 
now undermines the health and health care of far too 
many Americans. Medicare beneficiaries, who depend 
particularly on access to high-quality health care, stand 
to benefit substantially from such changes.
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